News you can use: health & drug safety updates

2019

  • April 11, 2019

    This webinar features discussion among opioid misuse health literacy experts about effective prevention strategies, approaches, and resources that can advance an understanding and a dialogue between older patients and their healthcare providers about opioid use. Presenters include prevention leaders from SAMHSA, the National Council on Aging, United Hospital Fund, and the Johns Hopkins Geriatric Workforce Enhancement program.

  • April 5, 2019

    From 2010 to 2015, the rate of opioid-related hospital stays increased between 27 and 39 percent among patients age 65 and older, depending on the age group. Non-opioid-related hospital stays decreased 17 percent for patients age 65 and older and during the same period (HCUP Statistitical Frief #244 — updated September 2018).

  • March 27, 2019

    Allied Against Opioid Abuse (AAOA) joined other leading national voices to raise awareness about the importance of prescription opioid safety. AAOA, along with the U.S. Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Administration, National Safety Council and others, contributed content to a special insert in USA Today as part of an opioid awareness issue developed by Mediaplanet. The BeMedWise Program at NeedyMeds is an AAOA National Partner.

  • March 20, 2019

    Most people struggling with an opioid addiction do not have access to medications that could help them, including methadone, buprenorphine and extended-release naltrexone, according to a report from the National Academies of Sciences, Engineering, and Medicine. The study found only 6% of treatment facilities offered all three of the drugs in 2016, while only 5% of those addicted to opioids received medication for the addiction.

  • March 13, 2019

    Many of the most frequently prescribed oral medications in the U.S. contain at least one ingredient that could cause an adverse reaction, new research shows. The study, reported in Science Translational Medicine, looked at more than 42,000 oral medications and identified more than three dozen inactive ingredients that have been described in medical literature to cause allergic symptoms following oral exposure.

  • March 13, 2019

    Poisoning is the number one cause of injury-related death in the U.S.. National Poison Prevention Week, sponsored by the National Poisoning Prevention Council during the third week in March, promotes poison prevention tips and the free emergency services provided by poison control centers, including the Poison Help hotline at 1-800-222-1222. Text POISON to 797979 to save the number in your smartphone.

  • February 21, 2019

    Google is partnering with the DEA, HHS, CVS, Walgreens and state governments to display local drug disposal locations in Google Maps. By entering searches such as "drug drop off near me" or "medication disposal near me," consumers will be able to find permanent disposal spots at local pharmacies, hospitals or government buildings to dispatch of unneeded medication. The program will start with 3,500 locations nationwide.

  • February 11, 2019

    The U.S. Food and Drug Administration (FDA) has warned more than a dozen companies against selling unapproved products which claim to treat Alzheimer's disease and other serious ailments, the agency said on Monday. Many of these drugs, marketed as dietary supplements and sold online, have not been reviewed by the FDA and their safety and efficacy remain unproven, the agency said in a statement. Reuters.

  • February 4, 2019

    Overdoses of the OTC diarrhea drug loperamide are increasing, according to new research from Rutgers University. Misuse of over-the-counter drugs with the ingredient loperamide can result in cardiac failure. The study notes that loperamide is available both online and in stores and is undetectable on routine drug tests. EurekeAlert!

  • January 31, 2019

    Current and former law enforcement and Drug Enforcement Agency (DEA) officials discussed their ongoing efforts to combat the counterfeit drug and fentanyl trade at Congressional Briefings hosted by the Partnership for Safe Medicines in Washington, D.C. BeMedWise and NeedyMeds participated in the briefings as named partners.

Pages